The cleanest peptide in the category: legal, prescribable, about $99/month, and not under FDA review. Here's the GHRH mechanism, what the evidence actually supports, and the honest case for and against.
Sermorelin is the cleanest peptide in the entire category — legal, prescribable, cheap, and not under FDA review. It reliably raises GH and IGF-1. Whether that produces the body-composition and anti-aging results it's sold for in healthy adults is a much weaker claim, and you should know which one you're buying.
Sermorelin acetate is a 29-amino-acid peptide — specifically, it's identical to the first 29 residues of your own growth-hormone-releasing hormone, GHRH(1–44). It is a secretagogue, not a hormone. It doesn't add growth hormone to your body. It walks up to your pituitary and tells it to release more of its own.
That distinction is the entire safety argument for sermorelin over HGH. Inject synthetic growth hormone and you override your body's feedback loop; the dose is whatever's in the syringe. Use a GHRH analog and your pituitary still governs the release — the negative-feedback loop stays intact, and somatostatin still puts a ceiling on it. You're amplifying a signal, not replacing an organ.
Sermorelin was FDA-approved — as Geref, by EMD Serono. It was discontinued in the US in 2008 for commercial reasons, not safety concerns. No brand-name sermorelin exists on the US market today.
Which means: the compounded market is the only sermorelin market. No brand comparator holding prices up. No insurance formulary. No patent. It's the one peptide where "compounded" isn't a downgrade — it's the only thing that exists.
Two different claims get deliberately blurred together in sermorelin marketing. Separate them.
| Claim | Evidence |
|---|---|
| Sermorelin raises GH and IGF-1 | Well established. This is what a GHRH analog does. It's the basis of the original approval. |
| Raising GH/IGF-1 improves body composition, recovery, sleep, and skin in healthy adults | Much weaker. Extrapolated largely from growth-hormone-deficiency populations. The evidence in healthy adults seeking optimization is thin. |
Anyone selling you sermorelin will show you the first claim and let you assume the second. The mechanism is real. The outcome data in people who aren't GH-deficient is not nearly as strong as the marketing implies. That doesn't make it useless — it makes it an experiment you're running on yourself, and the only way to run an experiment is to measure it.
These get lumped together constantly and they are not the same thing.
| Sermorelin | CJC-1295 | Ipamorelin | |
|---|---|---|---|
| Class | GHRH analog | GHRH analog | GHRP (ghrelin mimetic) |
| Receptor | GHRH receptor | GHS-R — a different receptor | |
| Half-life | Minutes — very short | Days (DAC version) | ~2 hours |
| Release pattern | Pulsatile — mimics physiology | Sustained elevation | Pulsatile |
| Prescribed online? | Widely | Rarely | Rarely |
The practical read: sermorelin's very short half-life is a feature, not a bug — it produces a pulse that resembles your natural GH rhythm, then clears. CJC-1295 with DAC produces a sustained "bleed" of GH that looks nothing like physiology, which is exactly why some clinicians prefer sermorelin and some prefer CJC.
Because sermorelin (GHRH) and ipamorelin (GHRP) hit two different receptors, stacking them produces a larger GH release than either alone. That's the reasoning behind the classic CJC-1295/ipamorelin protocol. It's also why a sermorelin-only protocol is the conservative, more physiological choice — and the one that's actually easy to get prescribed.
| Path | Monthly | Year one, realistic |
|---|---|---|
| Telehealth | ~$99 | ~$1,200 + labs |
| Local peptide clinic | $200–$400 | $3,000–$5,500 |
| Concierge / longevity clinic | $400+ | $5,000+ |
Telehealth has crushed the floor on this one. At around $99/month, sermorelin is one of the cheapest prescribed peptides available — and unlike BPC-157 or TB-500, you're not navigating a legal gray zone to get it.
Sermorelin is normally a nightly subcutaneous injection, dosed in micrograms (typically 200–500 mcg), taken at bedtime to align with your natural GH pulse. Two providers have pushed the price to the floor, and they differ on exactly one thing that matters: whether you have to inject.
Sermorelin from about $99/month, prescribed after an online intake reviewed by a US-licensed clinician. You pay nothing if you're not approved. Telos also runs the broadest peptide menu of any telehealth platform we've looked at — compounded PT-141, an NAD+ nasal spray (the only needle-free NAD+ format we've found), and separate men's and women's peptide programs.
Telos Rx is a technology and administrative platform, not a medical practice. Its own terms state it "does not provide any medical services" and instead connects you to a licensed medical group. That's legal and common in telehealth, but you should know who is clinically accountable before you start.
Also: its terms disclose that testimonial images may use models, and that people in its ads may be actors rather than patients. Treat the testimonials as marketing. Judge the program on price, pharmacy, and the clinician — not the before-and-afters.
Strut Health prescribes an oral sermorelin troche at roughly $99/month flat — a dissolving tablet instead of a nightly needle. Needle aversion is the single most common reason people never start a peptide protocol, so this is a genuinely useful option.
But be clear-eyed: sermorelin is a 29-amino-acid peptide, and peptides are poorly absorbed orally and sublingually relative to subcutaneous injection. The troche is a real option if you truly will not inject. It is not equivalent. Strut has also received an FDA warning letter, which we mention because you should know it.
IGF-1 is the downstream readout of growth hormone, and it is the only practical way to know whether sermorelin is doing anything at all. GH itself is pulsatile and useless to spot-check. IGF-1 is stable and tells you the truth.
Almost none of the telehealth providers above require it. Get it anyway. A baseline plus a 3-month retest costs less than one month of medication, and it's the difference between running a protocol and paying a subscription to hope.
A sensible baseline panel:
Yes. Sermorelin is a prescription medication, legally dispensed by 503A compounding pharmacies against a patient-specific prescription. Unlike BPC-157 or TB-500, it is not in a regulatory gray zone and is not part of the July 2026 FDA PCAC review.
The brand-name version, Geref, was FDA-approved — and was discontinued in the US in 2008 for commercial reasons, not safety. No brand-name sermorelin exists on the US market today. Every prescription you can actually fill is compounded, which makes the compounded market the only sermorelin market there is.
It reliably raises GH and IGF-1 — that part is well established. What is far less established is whether that translates into the body-composition and anti-aging outcomes it's marketed for in healthy adults. Be honest with yourself about which claim you're buying.
Sermorelin and CJC-1295 are GHRH analogs (they tell the pituitary to release GH). Ipamorelin is a GHRP — it works on a separate receptor. Sermorelin has a very short half-life (minutes); CJC-1295 is modified to last far longer. Stacking a GHRH with a GHRP hits both pathways, which is why CJC-1295/ipamorelin is the more common performance protocol.
Telehealth has driven the floor to about $99/month. Local peptide clinics run $200–$400/mo plus $150–$500 in consults and labs. Concierge clinics run $400+/mo. Add $95–$350 for the IGF-1 baseline and retest you should be doing regardless.
GHRH analogs are on the WADA Prohibited List (S2, Peptide Hormones). If you compete in a tested sport, sermorelin is a sanction risk regardless of the fact that it is entirely legal to be prescribed.
Our sister site Veritide independently scores every sermorelin telehealth provider on clinical oversight, pharmacy sourcing, and real pricing — including the ones it earns nothing from.